$3.26
00.00%
Last update: Sep 20, 4:02 PM
15 minutes delayed
Dare Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Dare Bioscience using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $-0.84 | $-0.72 | -16.7 % |
Dec 2023 | 2024-03-28 | $-0.72 | $-1.20 | 40.0 % |
Sep 2023 | 2023-11-09 | $-1.08 | $-1.20 | 10.0 % |
Jun 2023 | 2023-08-10 | $-1.20 | $-0.10 | -1100.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $22.44M | $5.89M | 280.9 % |
Mar 2024 | 2024-05-14 | $9.30M | $260.00K | 3477.7 % |
Dec 2023 | 2024-03-28 | $1.81M | $1.79M | 1.01 % |
Sep 2023 | 2023-11-09 | $1.00M | $430.00K | 132.6 % |
Dare Bioscience (DARE) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $1.52, which beat the estimate of $0.00.
The Actual Revenue was $22.4M, which beat the estimate of $5.9M.
Browse earnings estimates, EPS, and revenue on all stocks.